MedTrace Logo

Pharmacokinetic and Pharmacodynamic Study of a Novel Sublingual Aspirin Tablet

NCT04792723 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2021-03-11

No results posted yet for this study

Summary

The objective of the study is to compare the pharmacokinetics and pharmacodynamics of a new sublingual formulation of aspirin with that of oral aspirin when administered to healthy volunteers under fasting conditions. The test product is sublingual aspirin 80 mg manufactured by Vita Green Health Products Co. Ltd, Hong Kong and the reference product is oral aspirin 80mg tablet manufactured by Synco (HK) Ltd, Hong Kong.

Conditions

Interventions

DRUG

Sublingual aspirin

Vita Green Health Products sublingual aspirin 80 mg tablet

DRUG

Oral aspirin

Synco (HK) oral aspirin 80mg tablet

Sponsors & Collaborators

  • Vita Green Health Products Co. Ltd

    lead INDUSTRY

Principal Investigators

  • Elaine Chow · Chinese University of Hong Kong

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-05
Primary Completion
2021-07-01
Completion
2021-09-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04792723 on ClinicalTrials.gov